Skip to main content
Veterinary Medicines

PALMIVAX

Authorised
Ta podatek za to zdravilo ni na voljo.

Identifikacija zdravila

Ime zdravila:
PALMIVAX
Učinkovina:
Ta podatek za to zdravilo ni na voljo.
Pot uporabe:
  • intramuskularna uporaba
  • Subkutana uporaba

Podatki o zdravilu

Učinkovina / Jakost:
Ta podatek za to zdravilo ni na voljo.
Farmacevtska oblika:
  • Liofilizat in vehikel za suspenzijo za injiciranje
Withdrawal period by route of administration:
  • Intramuscular use
    • Duck
      • All relevant tissues
        0
        day
    • Goose
      • All relevant tissues
        0
        day
  • Subcutaneous use
    • Duck
      • All relevant tissues
        0
        day
    • Goose
      • All relevant tissues
        0
        day
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QI01DD01
Status dovoljenja:
  • Valid
Authorised in:
  • France
Opis ovojnine:

Dodatne informacije

Entitlement type:
Imetnik dovoljenja za promet z zdravilom:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Boehringer Ingelheim Animal Health France
Pristojni organ:
  • French Agency For Food, Environmental And Occupational Health & Safety
Številka dovoljenja :
  • FR/V/0393979 4/1982
Datum spremembe statusa dovoljenja:

Dokumenti

Povzetek glavnih značilnosti zdravila

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.
French (PDF)
Objavljeno na: 4/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."